IDO1 Mouse Monoclonal Antibody [Clone ID: 10.1]
CAT#: TA319542
Mouse monoclonal anti-IDO1 antibody
Need it in bulk or conjugated?
Get a free quote
CNY 8,303.00
Cited in 1 publication. |
CNY 300.00
CNY 1,430.00
CNY 2,900.00
CNY 6,650.00
Specifications
Product Data | |
Clone Name | 10.1 |
Applications | WB |
Recommend Dilution | ELISA: 1:5000-1:50000, WB: 1:500-1:1500, IHC: 1:100-1:500, IF: 1:50-1:100, IP: 10-100 uL |
Reactivity | Human, Mouse |
Host | Mouse |
Clonality | Monoclonal |
Immunogen | Anti-IDO1 (MOUSE) Monoclonal Antibody was produced in mouse by repeated immunizations with fragment of recombinant human and mouse IDO1 protein followed by hybridoma development. |
Formulation | 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2 |
Concentration | lot specific |
Conjugation | Unconjugated |
Storage Condition | Store at -20°C as received. |
Gene Name | indoleamine 2,3-dioxygenase 1 |
Database Link | |
Synonyms | IDO; IDO-1; INDO |
Note | Indoleamine 2, 3-dioxygenase1 (IDO1) is a 41-42 kD intracellular enzyme that catabolizes tryptophan into kynurenine. IDO1 modulates levels of the amino acid tryptophan, which is vital for cell growth, but is also involved in the suppression of the immune response. IDO1 effects on immune suppression are due to decreased tryptophan availability and the generation of tryptophan metabolites, resulting in negative effects on T lymphocytes, including proliferation, function and survival. IDO1 may be involved in the suppression of the immune response to tumors, and blocking the IDO1 pathway may be a potential target for immuno and cancer therapy. IDO1 is expressed in a wide variety of tissues and can be upregulated by interferon gamma and other inflammatory cytokines. |
Reference Data | |
Protein Families | Druggable Genome |
Protein Pathways | Metabolic pathways, Tryptophan metabolism |
Citations (1)
The use of this Antibodies has been cited in the following citations: |
---|
Indoleamine 2,3-dioxygenase 1 and programmed cell death-ligand 1 co-expression correlates with aggressive features in lung adenocarcinoma.
,null,
European journal of cancer (Oxford, England : 1990)
,PubMed ID 30014971
[IDO1]
|
Documents
Product Manuals |
FAQs |
SDS |
Resources
抗体相关资料 |